Infusive Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$7.34M |
| 2 |
Colgate-Palmolive
CL
|
+$6.53M |
| 3 |
Tesla
TSLA
|
+$6.12M |
| 4 |
Coca-Cola
KO
|
+$5.86M |
| 5 |
Shopify
SHOP
|
+$5.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$8.41M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$7.64M |
| 3 |
Ulta Beauty
ULTA
|
+$6.98M |
| 4 |
Amazon
AMZN
|
+$6.31M |
| 5 |
Meta Platforms (Facebook)
META
|
+$5.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 40.23% |
| 2 | Consumer Staples | 31.32% |
| 3 | Communication Services | 13.59% |
| 4 | Financials | 10.11% |
| 5 | Technology | 4.75% |
Similar funds
Infusive Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Infusive Asset Management held 46 positions worth $225M, down 5.3% from $237M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Infusive Asset Management withdrew a net $21.8M in Q4 2024, closing 9 positions and reducing 18 holdings. Its most notable exit was Ulta Beauty, an estimated $6.98M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, Infusive Asset Management opened a new position in Tesla worth $7.69M.
- Infusive Asset Management's largest Q4 2024 buy was Tesla: 19,035 shares worth $7.69M.
- Infusive Asset Management added most to Costco in Q4 2024, an estimated $7.34M increase.
- Infusive Asset Management's biggest Q4 2024 reduction was McDonald's, cutting an estimated $8.41M.
- Infusive Asset Management fully exited Ulta Beauty in Q4 2024, selling an estimated $6.98M.
- Infusive Asset Management's ten largest holdings make up 48% of its $225M portfolio in Q4 2024.
- Infusive Asset Management opened 8 new positions and closed 9 in Q4 2024.
- Infusive Asset Management's portfolio value fell 5.3% quarter-over-quarter to $225M.
Based on Infusive Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.